Literature DB >> 3005428

Varicella-Zoster virus does not become more resistant to acyclovir during therapy.

N L Cole, H H Balfour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3005428     DOI： 10.1093/infdis/153.3.605

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Acyclovir for childhood chickenpox. No reason not to treat.

Authors:  H H Balfour
Journal:  BMJ       Date:  1995-01-14

2.  Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.

Authors:  K R Beutner; D J Friedman; C Forszpaniak; P L Andersen; M J Wood
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

Review 3.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

Review 4.  Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.

Authors:  R Snoeck; G Andrei; E De Clercq
Journal:  Drugs       Date:  1999-02       Impact factor: 11.431

Review 5.  Acyclovir for treating varicella in otherwise healthy children and adolescents: a systematic review of randomised controlled trials.

Authors:  Terry P Klassen; Elaine M Belseck; Natasha Wiebe; Lisa Hartling
Journal:  BMC Pediatr       Date:  2002-09-30       Impact factor: 2.125

Review 6.  Antiviral agents.

Authors:  E D Reines; P A Gross
Journal:  Med Clin North Am       Date:  1988-05       Impact factor: 5.456
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.